Format

Send to

Choose Destination
Nat Biotechnol. 2015 May;33(5):449-51. doi: 10.1038/nbt.3221.

Precision medicine and the FDA's draft guidance on laboratory-developed tests.

Author information

1
1] Faculty of Arts and Sciences, Harvard University, Cambridge, Massachusetts, USA. [2] The Blackstone Group, London, United Kingdom.
2
Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
3
Program on Regulation, Therapeutics and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
PMID:
25965745
DOI:
10.1038/nbt.3221
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center